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Abstract
Multiple sclerosis (MS), a neuroinflammatory disease, has few treatment options, none entirely 
adequate. We studied whether prolonged electrical stimulation of a hindbrain region (the nucleus 
raphe magnus) can attenuate experimental autoimmune encephalomyelitis, a murine model of MS 
induced by MOG35-55 injection. Eight days after symptoms emerged, a wireless electrical 
stimulator with a connectorless protruding microelectrode was implanted cranially, and daily 
intermittent stimulation of awake, unrestrained mice began immediately. The thoracic spinal cord 
was analyzed for changes in histology (on day 29) and gene expression (on day 37), with a focus 
on myelination and cytokine production. Controls, with inactive implants, showed a phase of 
disease exacerbation on days 19–25 that stimulation for >16 days eliminated. Prolonged 
stimulation also reduced infiltrating immune cells and increased numbers of myelinated axons. It 
additionally lowered gene expression for some pro-inflammatory cytokines (interferon gamma and 
tumor necrosis factor) and for platelet-derived growth factor receptor alpha, a marker of 
oligodendrocyte precursors, while raising it for myelin basic protein. Restorative treatments for 
MS might profitably consider ways to stimulate the raphe magnus, directly or via its inputs, or to 
emulate its serotonergic and peptidergic output.
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Introduction
Multiple sclerosis (MS) is a chronic autoimmune disease characterized by localized 
destruction of the myelin sheets that enwrap and support axons of the central nervous system 
(CNS) (Friese et al., 2014; Mohan et al., 2014). The etiology is unknown and a satisfactory 
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cure is elusive. Current therapies are limited to systemic administration of immune-
modulating agents that can reduce infiltration of peripheral immune cells and thereby 
dampen inflammatory signals in the CNS (Minagar, 2013; Ransohoff et al., 2015). An 
alternative possible approach, as in the present paper, is to address directly the loss of myelin 
and axons that underlies the permanent disability of progressive forms of MS (Fitzner and 
Simons, 2010).
We previously showed that prolonged electrical stimulation in one of the serotonergic raphe 
nuclei of the brainstem promotes recovery after neurotrauma in rats. The ascending systems 
of the median or dorsal raphe of the midbrain, when stimulated intermittently for one week 
(8 Hz, 5 minutes on-off cycling, 12 hours daily) beginning several hours after traumatic 
brain injury, enhanced both behavioral and gross anatomical recovery (Carballosa Gonzalez 
et al., 2013). The hindbrain’s nucleus raphe magnus (NRM), a major source of spinal cord 
serotonin, similarly improved motor recovery from spinal cord injury (Hentall and Burns, 
2009; Hentall and Gonzalez, 2012) while augmenting myelin sparing and serotonergic 
innervation around the injury site. Consistent with a primarily restorative role, all tested 
raphe regions proved to be non-eloquent, evoking no apparent motor or aversive effects and 
thus allowing problem-free prolonged stimulation.
These prior results suggested that raphe stimulation could reduce or even reverse the 
functional and anatomical degeneration associated with progressive forms of MS. A first 
exploration of this possibility is reported here. We studied a common mouse model of MS, 
experimental autoimmune encephalomyelitis (EAE), which is induced by injection of 
myelin-derived peptides (Procaccini et al., 2015) and tends to cause strong spinal cord 
deficits. The NRM was selected as the stimulation target because of its direct descending 
projection and its previously demonstrated benefits for myelination. The analysis included a 
daily score of overt symptoms (EAE score), histological examination of myelination and 
tissue infiltration, and real-time polymerase chain reaction (PCR) measurement of 
expression for myelination-related proteins and cytokines in thoracic spinal cord. Injection 
of the 35-55 peptide fragment of myelin oligodendrocyte glycoprotein (MOG35-55) caused a 
typical progression of overt disease in untreated animals: an acute inflammatory phase that 
reached a peak 4 to 6 days after the first symptoms emerged and a later exacerbation in 
approximately the 3rd week. Beyond this time point, untreated EAE declined rapidly, 
precluding study of more prolonged treatment; hence euthanasia was done on the 29th or 
37th day. To minimize the surgical risks of general anesthesia during the acute phase and to 
obtain a stable baseline period of disease, the wireless electronic stimulator and integral 
electrode were implanted on the 8th day of symptoms. Long-term stimulation began 
immediately after implantation.
Materials and Methods
Study Design
Mice (20 control, 20 stimulated) were studied in four sequential batches, within which they 
were alternatingly assigned to stimulated and control groups. These group sizes were used 
because they equaled or exceeded group sizes giving satisfactory statistical power in prior 
studies of NRM stimulation for spinal cord injury and drug treatment for EAE (Hentall and 
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Gonzalez, 2012; Madsen et al., 2016). Clinical signs of EAE were assessed daily by the 
same trained and blinded observer. Later histological analysis was also conducted by 
persons blinded to the treatment. Days are numbered in this article with reference to EAE 
onset (“disease day”) unless otherwise specified. Onset of symptoms occurred 20 ±0.9 days 
(mean ± SEM) after induction. Stimulators were implanted and the stimulation program 
activated on disease day 8. A control group was treated identically, except the implant 
remained inactive. The first two batches underwent euthanasia on disease day 29. The last 
two batches underwent euthanasia on disease day 37 ±1. Mice used in Subsets were selected 
for histological analysis at disease day 29 and for real-time PCR analysis at disease day 37 
based on longevity of stimulation (≥17 days) and on the closest matching EAE scores on day 
8 in controls.
The statistical analysis of EAE scores used SPSS (version 21: IBM Corp.). A two-sided 
significance level of p≤0.05 was applied; effect size (partial eta-squared) for individual 
variables is also reported when available. To examine the effect of stimulation on EAE 
scores, a repeated-measures analysis of variance (ANOVA) compared treated and control 
groups during disease exacerbation. Parametric t-tests for treatment differences on individual 
days were derived from the repeated measures software routine. To assess the mean time-
course of EAE after cessation of stimulation, the score for a given day in each stimulated 
mouse was first subtracted from the mean control (untreated) EAE score for the same 
disease day, and days were then renumbered relative to their last day of stimulation, before 
being finally averaged across subjects for each post-stimulation day. The significance of the 
difference between a given day and all preceding days was provided by within-subject 
contrasts after repeated measures ANOVA. Results of real-time PCR were analyzed by the 
independent samples exact Mann-Whitney test and results of the histological quantification 
by unpaired (unequal variance) t-tests, both using Prism software (GraphPad Inc., version 
6.05).
Mice
Six-week old female C57BL/6 mice were obtained from Jackson Laboratory. They were 
housed in individually ventilated cages in a virus/antigen-free facility on a 12-hour light/
dark cycle and given free access to food and water. All experiments were performed in 
accordance with protocols and guidelines approved by the local Institutional Animal Care 
and Use Committee.
MOG35-55-induced Experimental Autoimmune Encephalomyelitis
Active EAE was induced in mice aged 2–3 months by injection of MOG35-55 peptide, as 
described previously (Madsen et al., 2016). It was measured on a standard scale from 0 to 6, 
as follows: 0, no clinical signs; 1, loss of tail tone; 2, fully flaccid tail; 3, complete hind limb 
paralysis; 4, complete forelimb paralysis; 5, moribund; 6, dead (0.5 gradations were used for 
intermediate scores).
Stimulators
The self-powered, wireless, epoxy-embedded stimulators with infrared readout (Figs. 1A, B) 
were fabricated in-house based on a previously published design for rats (Hentall, 2013). 
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The main modifications were smaller size (dimensions 10 mm long, 5.5 mm wide and 5 mm 
high) and control by visible light instead of magnetic pulses. A commercially obtained 
tungsten microelectrode of 0.5 megohm nominal impedance (A-M Systems, Inc., Sequim, 
WA; catalog number 573210) emerged directly from the epoxy capsule along with a 
stainless steel wire anode. Through a step-up voltage regulator with current feedback, the 
microprocessor-based program delivered constant-current cathodal pulses of 30 μA 
amplitude and 1 ms duration at 8 Hz during 12 daylight hours in an alternating pattern of 5 
minutes on and 5 minutes off. Pulses of amplitude 30 μA are estimated to activate the 
average NRM cell body within a radius of 190 μm, well inside the dimensions of the 
nucleus, based on measured threshold-distance relations in the rat’s NRM (Hentall et al., 
1984).
Surgical Implantation and Stimulation
Mice were anesthetized with 1.2% isoflurane in oxygen. The microelectrode was placed 
stereotaxically through a burr hole in the midline NRM (1.8 mm posterior and 5.8 mm 
below the interaural line in flat-skull orientation). The anode wire was wrapped around a 
stainless steel miniature screw in the skull. There was approximately 1 mm clearance 
between the stimulator capsule and skull. Dental cement fixed the stimulator to the screw 
and skull. The skin incision was closed posteriorly by sterile sutures. Post-operative care 
included subcutaneously injecting buprenorphine (0.2mg/kg bid for 3 days) for analgesia 
and gentamycin (5mg/kg bid for 7 days) to prevent infection. The status of the stimulation 
program was signaled by width-modulated infrared pulses, and was checked at least once 
per day by means of a custom-built reader. Failure to detect an infrared signal was taken to 
indicate a non-functional stimulator, and this status was ensured by applying the inactivating 
sequence of light pulses.
Perfusion and Histological Analysis
Mice used for histological analysis were euthanatized by i.p. injection of 100mg/kg 
ketamine and 10mg/kg xylazine. The brain and spinal cord were sectioned coronally at 1 μm 
thickness and stained with 1 % toluidine blue. Sections were examined by light microscopy 
(Zeiss) at 63X magnification and infiltrating cells, myelinated and collapsed axons were 
quantified by Stereoinvestigator (MicroBrightField Inc.) software. The number of infiltrating 
cells was expressed per area of section. Because the tissue area shrinks considerably with 
demyelination or axon collapse in EAE, axons were quantified simply by total count. 
Locations of stimulation electrodes were verified in a subset of mice by examining sagittal 
or coronal sections near the midline (n=8). Some brains were sectioned at 10 μm thickness 
and stained with hematoxylin-eosin. Other brains were cut as 30 μm sagittal sections 
immunostained with mouse anti-NeuN (1:500, Millipore), rabbit anti-GFAP (1:1000, 
Millipore) and Vectashield DAPI mounting medium (VectorLabs). Tips of the electrode 
proved always to lie in the cytologically defined region of the NRM (Figs. 1C, D). The 
electrode track was associated with mild astrocytic activity along the track and minimal 
tissue damage (Fig. 1C).
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Total RNA isolation and Real-time PCR
Total RNA was isolated from PBS perfused, fresh frozen spinal cord tissue using Trizol 
Reagent (Invitrogen) in accordance with the manufacturer’s protocol. Remaining DNA and 
protein residue was removed using the RNeasy Mini Kit (Qiagen) in combination with on-
column DNA digestion using the RNase-Free DNase Set (Qiagen), performed in accordance 
with the manufacturer’s protocol. For each sample, 0.5 mg RNA was reverse-transcribed 
with Omniscript RT kit (Qiagen). The complimentary DNA was used as template for a real 
time PCR reaction using the Rotor-Gene SYBR Green PCR Kit (Qiagen). Gene expression 
was quantified for myelin basic protein (MBP), Notch1, platelet-derived growth factor 
receptor alpha (PDGFRα), interferon gamma (IFNγ), interleukin-1β (IL-1β) and tumor 
necrosis factor (TNF), all normalized to expression of glyceraldehyde 3-phosphate 
dehydrogenase (GADPH). See Table 1 for gene-specific primer list.
Results
Effect of NRM stimulation on EAE scores
The planned timeline was to give stimulation until the day of euthanasia (Fig. 2A), but this 
was precluded by the stimulator battery lifetime, whose median was 17.5 days (estimated by 
Kaplan-Meir analysis, ± 1.8 SEM, n=20). Thus it was possible to give prolonged stimulation 
in most mice for the majority of days planned. Stimulated mice were divided into two main 
groups. One group (n=9) received longer stimulation that lasted through all or most of the 
late phase of disease exacerbation, occurring on disease days 19–26; the range of stimulator 
lifetimes was 17–29 days (until disease days 25–37). The late phase, readily apparent in 
controls (n=12), was essentially absent after the longer stimulation (Fig. 2B). The difference 
between the control group and the longer-stimulated group over the 7 days of disease 
exacerbation was statistically significant. Individual days within this 7-day range, except 
disease day 20, also showed significant treatment differences. Due to a rapid decline in 
untreated disease, EAE scores converged in control and stimulated groups around disease 
day 29. The other main group of stimulated mice (n=7) received 4–15 days of stimulation 
(until disease days 12–23). This shorter stimulation had no significant effect on the course of 
the mean EAE score referenced to the first day of symptoms (Fig. 2C).
The duration of effects beyond the end of stimulation was analyzed by averaging scores 
referenced to the last day of stimulation. Two ranges of stimulation were available, 4–7 days 
(n=4) and 15–21 days (n=6); beyond 21 days, the time series were too short to analyze. 
Stimulation for 4–7 days was followed by a growing difference between the falling score of 
this group and the more stable control score (Fig. 2D). The difference was visually apparent 
after 4 days and continued for 7 more days before subsiding over the next 4 days; it was 
significant on days 10 and 11 compared to prior days. In mice that received 15–21 days of 
stimulation, there was an immediate post-stimulation difference from the control scores that 
slowly disappeared over 6 days (Fig. 2D); the difference was significant on days 4 and 5.
Myelin, axon pathology and immune cell infiltration
A random sample of mice that received longer stimulation (mean 19.4 days ±1.5 SEM, n=5) 
were examined for histopathological damage on disease day 29 in comparison with a sample 
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of matched controls (n=5). Our previous studies have shown that the presence of EAE more 
than doubles immune cell infiltration and collapsed axons compared to non-diseased mice 
while numbers of myelinated fibers are less than half (Brambilla et al., 2011). All mice 
showed widespread axonal loss and immune cell infiltration that was visibly less severe in 
stimulated mice (Fig. 3A). Stimulation significantly increased the number of myelinated 
axons (Fig. 3B) and lowered the density of infiltrating cells in the white matter parenchyma 
(Fig. 3D). There was no significant difference detected in the number of collapsed 
(degenerating) axons (Fig. 3C).
Expression of myelin-related genes and pro-inflammatory cytokines
A different sample of longer-term stimulated mice (≥17 days) and control mice was 
examined on disease day 37 for expression of some genes of interest in EAE. Stimulation 
significantly elevated the expression of MBP (Fig. 4A), which is expressed exclusively by 
mature oligodendrocytes. There was a concomitant reduction in the expression of PDGFRα 
(Fig. 4C), which specifically marks oligodendrocyte precursor cells (OPCs). Notch1, a 
negative regulator of OPC differentiation, did not differ significantly between stimulated and 
control mice (Fig. 4B). Expression of three inflammatory cytokines that are important in MS 
and EAE was also measured. IFNγ and TNF were both significantly reduced by stimulation, 
but the effect on IL-1β did not reach significance (Figs. 4, D–F). The cytokine data showed 
considerably greater scatter within the stimulated group than within controls, implying 
random variability in treatment parameters (electrode position or duration of stimulation, for 
example).
Discussion
This study assumed a general model of CNS repair, in which the several raphe nuclei of the 
brainstem provide critical relay points in parallel restorative feedback loops. Axon terminals 
of raphe neurons are essentially ubiquitous in the CNS (Baumgarten and Grozdanovic, 
1995), mostly releasing serotonin, a classical fast neurotransmitter that also has major 
neurotrophic actions (Azmitia, 2007). Conversely, serotonergic terminals in the CNS all 
appear to originate in cell bodies of brainstem raphe nuclei. Stimuli that cause raphe neurons 
to fire include some typical sensory and chemical sequelae of trauma. For example, NRM 
neurons respond to nociception, hypothermia, prostaglandins and hypercapnia (Fields et al., 
1991; Rathner et al., 2001; Nason and Mason, 2006; Teran et al., 2014). A clinical prediction 
of this model is that boosting the feedback signal will enhance recovery from neurotrauma. 
Such proved to be the case in several of our experimental studies in rats (described in the 
Introduction). Additional support is here provided in a different species (mice) and a non-
traumatic, neurodegenerative disease (EAE). In future, given that CNS damage is widely 
disseminated in progressive MS, the midbrain raphe nuclei, whose projections provide the 
majority of ascending serotonergic terminals, should be explored for their capacity to 
produce a parallel reduction of forebrain damage in EAE.
With regard to the mechanism whereby the NRM initiates this repair, part of the explanation 
may be found in the immune-modulatory and neuroprotective actions of serotonin (Azmitia, 
2007; Berger et al., 2009). Microstimulation in the NRM has been clearly demonstrated to 
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release serotonin in the rat’s spinal cord (Hentall et al., 2006). NRM stimulation with 
parameters used in this study (30 μA pulses in 8 Hz trains) has also been found to increase 
trophic signaling molecules cyclic AMP, pPKA and pCREB in the injured thoracic spinal 
cord of the rat that are blocked by the 5-HT7 receptor antagonist pimozide (Carballosa-
Gonzalez et al., 2014). Furthermore, some findings with re-uptake inhibitors suggest that 
serotonin dampens the symptoms of EAE (White et al., 1992; Vollmar et al., 2009). Many 
serotonergic terminals co-release one of several neuropeptides, prominently galanin, 
substance P, met-enkephalin, thyrotropin-releasing hormone (Hokfelt et al., 2000; Hodges 
and Richerson, 2008). These are also potentially beneficial in neurodegeneration; galanin is 
upregulated in EAE and slows demyelination (Wraith et al., 2009; Yin et al., 2012), and 
thyrotropin releasing hormone and substance P also neurotrophic or protective effects 
(Jantas et al., 2009; Kim et al., 2015). Conceivably, serotonin and one or more of these 
neuropeptides have synergistic effects when simultaneously released, but spinal cord assays 
of these neuropeptides during and after raphe stimulation, and analysis of their specific 
effects, remain to be done in relevant experimental models.
Shorter-term NRM stimulation (4–7 days) had a delayed and transitory effect on EAE 
scores. This suggests, first, that the underlying evoked trophic changes develop over several 
days and, second, that causative disease factors continue to be present. Longer- term 
stimulation led to enduring tissue changes that outlasted the stimulation by at least several 
days, including increases in myelinated axons seen on day 29. The stimulation-produced rise 
in gene expression for MBP and decreases in PDGFRα, IFNγ and TNF seen on day 37 also 
outlasted the differences in overt disease between treated and control mice, which 
disappeared around day 28. PDGFRα marks OPCs, which thus may have differentiated into 
myelin-forming oligodendrocytes under the influence of the NRM stimulation. Although 
oligodendrocytes and their precursor cells apparently lack 5-HT receptors, astrocytes 
strongly express 5-HT2 and 5-HT7 receptors (Maxishima et al., 2001; Doly et al., 2005). 
Astrocytes in turn can bi-directionally modulate the development and functioning of 
oligodendrocytes (Barnett and Linington, 2013), and probably promote myelination by 
increasing cAMP, leading to release onto oligodendrocyte receptors of pro-myelinating 
signals (Ballotti et al., 1987; Xiao et al., 2010; Yin et al., 2012).
EAE is largely mediated by infiltration into the CNS of immune cells, especially 
lymphocytes and monocytes/macrophages, with a critical role for cytokines in amplifying 
the local immune response (Eng et al., 1996). EAE greatly increases expression of the three 
studied pro-inflammatory cytokines TNF, IFNγ and IL-1β, compared to naive mice, as 
observed, for example, 25 days post-induction (Madsen et al., 2016). It is important to note 
that the functional significance of these results is complicated, because some pro-
inflammatory cytokines contribute to neuroprotection and plasticity (Schattling et al., 2014). 
However, in the present study, NRM stimulation enduringly reduced both the infiltration of 
immune cells into the spinal cord and the expression levels of these three cytokines. The 
infiltrating immune cells may have responded to serotonin released by the NRM in the local 
microenvironment, since serotonin derived from platelets regulates circulating macrophage 
and lymphocytes and the synthesis of cytokines such as TNF (Kubera et al., 2005; Ahern, 
2011; Baganz and Blakely, 2013).
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The main treatments for MS are currently provided by anti-inflammatory agents such as 
methylprednisolone and other immune-modulators such as interferon-β. The present 
findings imply that therapies directed against the neuropathic consequences of the 
inflammation could also prove helpful. One experimental approach may be to give a 
combination of mimetic drugs for serotonin and one or more neuropeptides. Another 
approach, stemming more directly from the present study, is electrical deep brain stimulation 
(DBS). DBS in the NRM is untried and appears a priori very risky for human treatment, due 
to its location near vital hindbrain centers, despite the apparent safety and feasibility in 
rodents, as revealed in the present study. This difficulty may potentially be avoided by 
stimulating the periaqueductal gray (PAG), an established neurosurgical target in the 
midbrain that has a strong, direct excitatory effect on NRM neurons (Behbehani and Fields, 
1979). For MS patients, a subsidiary advantage of PAG stimulation may be reduction in 
debilitating pain, found in about 70% of patients with progressive MS (Foley et al., 2013). In 
rats, long-term PAG stimulation produced restorative effects after thoracic SCI similar to 
those of the NRM (Hentall and Gonzalez, 2012). A clinical trial of prolonged PAG 
stimulation for neuropathic pain and other degenerative symptoms of SCI is under way 
(Hentall et al., 2016). This same intervention might be productively explored in select 
groups of patients with progressive MS.
Conclusions
In a mouse model of multiple sclerosis, prolonged electrical stimulation in the brainstem 
(raphe magnus region) enduringly suppressed the overt disease, decreased demyelination 
and lowered cytokine production, thus suggesting new treatment strategies.
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MS multiple sclerosis
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MBP myelin basic protein
PDGFRα platelet-derived growth factor receptor alpha
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Highlights
• We proposed that brainstem activity can reverse experimental autoimmune 
encephalomyelitis, a model of multiple sclerosis.
• The nucleus raphe magnus of the mouse’s hindbrain was wirelessly 
stimulated for up to several weeks.
• The stimulation reduced overt symptoms and lastingly increased myelination.
• After stimulation, immune cell invasion and some inflammatory cytokines 
were lower for at least several days.
• These findings confirm the restorative role for raphe nuclei suggested by prior 
studies of neurotrauma
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Fig. 1. 
Stimulators and histology. (A) Encapsulated stimulators just before implantation, showing 
protruding electrodes (wire anode and microelectrode cathodes). (B) An awake mouse with 
an implanted working stimulator. (C) Immunostained sagittal section through the brainstem, 
including gliosis around the electrode task. Red: NeuN; green, GFAP; blue, DAPI. Scale bar 
= 0.5 mm. (D) A sagittal section through the midline of the brainstem, stained with 
hematoxylin-eosin, showing the approximate trajectory of the microelectrode through the 
cerebellum and dorsal medulla. The abbreviation CC marks the start of the spinal central 
canal. The dotted line outlines the NRM.
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Fig. 2. 
Electrical stimulation of NRM is protective in EAE. (A) Experimental timeline, as planned. 
(B) Time course of EAE, starting with the day of its first appearance, in the control (‘sham’) 
group and in mice receiving more than 16 days of stimulation (‘stim’). Stimulation was 
initiated on day 8. Results are expressed as daily mean scores ± SEM; n=12 for control 
group and n=9 for the stimulated group. The broken line indicates the percentage of 
functioning stimulators on a given day. The bar marked by an asterisk shows the 7 days of 
peak EAE subjected to repeated measures ANOVA (F1,19=6.71, p=0.020, partial eta-
squared=0.30). Enlarged symbols indicate significant differences from the control group 
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found in t-tests on individual days (p≤0.05); day 19: t19=|2.24|, p=0.040; day 21: t19=|2.28|, 
p=0.037; day 22: t19=|2.23|, p=0.041; day 23: t19=|2.67|, p=0.017; day 24: t19=|2.80|, 
p=0.013; day 25: t19=|2.55|, p=0.022. (C) EAE scores for mice receiving stimulation for 4–
15 days (n=7); the curve for control mice (n=12) appears also in graph B. (D) EAE score 
plotted against the numbers of days after cessation of stimulation. The daily score for an 
individual mouse was subtracted from the mean control score for the same post-disease day, 
and scores were averaged within each day counting from the end of stimulation (designated 
as day 1). Enlarged symbols represent significant within-subject contrasts for differences 
between the data point and all previous times (p≤0.05), as determined by repeated measures 
analysis. After stimulation for 4–7 days (n=4), days showing significant differences were 
day 10 (F1,3=10.4, p=0.045, partial eta-squared=0.78) and day 11 (F1,3=10.1, p=0.048, 
partial eta-squared=0.78). After stimulation for 15–21 days (n=6), days showing significant 
differences were day 4 (F1,5=10.6 p=0.022, partial eta-squared=0.68) and day 5 (F1,5=7.0, 
p=0.046, partial eta-squared =0.53).
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Fig. 3. 
Histological analysis of spinal cord. (A): Toluidine blue staining of semi-thin thoracic spinal 
cord sections. Images of representative areas were acquired in the white matter of control 
(‘sham’) mice and stimulated (‘stim’) mice. Solid black arrows show collapsed axons and 
smaller arrows with white interiors show infiltrating cells. The scale bar in the lower left of 
the panel is 10 μm. Stereological quantification of myelinated axons (B), collapsed axons 
(C) and infiltrating cells (D) in the thoracic white matter of control mice (n=5) and 
stimulated mice (n=5). The vertical scale reflects the total counted axons within the sampled 
tissue (B, C) or infiltrating cells per area of the thin sections (D). Horizontal bars represent 
the mean. Asterisks above the column of the stimulated group indicate significant contrasts. 
The stimulated group received 19.4 ±1.5 (mean ±SEM) days of stimulation. Differences 
were significant (p≤0.05) in unpaired t-tests for myelinated axons (t8=3.584, p=0.007, partial 
eta-squared=0.62) and infiltrating cells (t8=2.591, p=0.032, partial eta-squared=0.46), but 
not for collapsed axons.
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Fig. 4. 
Gene expression profiling in the thoracic spinal cord after EAE. Gene expression levels were 
evaluated 37 days after EAE symptoms emerged in samples of control (‘sham’) mice (filled 
squares) and stimulated (‘stim’) mice (filled circles). Expression of the gene of interest was 
normalized to GAPDH expression and results in the treated group are graphed as percent of 
the mean of the corresponding control group. Horizontal bars indicate medians for each 
group. Note the cytokines (lower three graphs) are displayed on logarithmic vertical axes, 
which are better to show the large range of values in stimulated mice. Mean days of 
stimulation ranged over groups from 18.4 to 22.8. Groups sizes were MBP stimulated n=7, 
control n=10; Notch1 stimulated n=8, control n=10; PDGFRα stimulated n=6, control n=9; 
TNF stimulated n=7, control n=10; IFNγ stimulated n=6, control n=10; IL-1β stimulated 
n=5, control n=11. Group sizes varied due to occasional problems with the chemical assay. 
Significant values in the Mann-Whitney test were for MBP U=10.00, 7, 10, p=0.015; for 
PDGFRα U=6.00, 6, 9, p=0.012; for TNF U=11.00, 7, 10, p=0.018; for IFNγ U=9.00, 6, 10, 
p=0.023. Significance is indicated on graphs by an asterisk above the column of the 
stimulated group.
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Table 1
Primers for real-time PCR gene amplification
Gene Primer Sequence Product Length Optimal Atemp
MBP F: 5′ cggggctctggcaaggactcacac 3′R: 5′ tggactactgggttttcatctt 3′ 101 bp 54.3°
Notch1 F: 5′ gaggtcaacgagtgcaacagtaac 3′R: 5′ctccacccaggggcacagtcac 3′ 92 bp 55.4°C
PDGFRα F: 5′ cctggcatgatggtcgattctact 3′R: 5′ ggtctcttctcgggctcactgttc 3′ 134 bp 55.3°C
IFNγ F: 5′ aggaactggcaaaaggatggtgac 3′R: 5′ tgacgcttatgttgttgctgatgg 3′ 118 bp 53.1°C
IL1β F: 5′ cttcaaatctcacagcagcacatc 3′R: 5′ ccacgggaaagacacaggtag 3′ 102 bp 53.4°C
TNF F: 5′ aggcactcccccaaaagatg 3′R: 5′ tcaccccgaagttcagtagacaga 3′ 123 bp 56.6°C
GAPDH F: 5′ gaggccggtgctgagtatgtcgtg 3′R: 5′ tcggcagaaggggcggagatga 3′ 116 bp 59.3°C
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